Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions.
Aslanyan G, Amroyan E, Gabrielyan E. Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions Phytomedicine, 2010. PMID 20374974
- Design
- Randomized, double-blind, placebo-controlled pilot (phase IIa), single dose, two parallel groups
- Sample
- n = 40
- Population
- Healthy women aged 20-68 reporting long-term stress
- Funding
- not stated in the PubMed or Crossref record; full text not read